What is clinically relevant? [Design Issues]

posted by bebac_fan – US, 2018-04-06 20:53 (1340 d 23:00 ago) – Posting: # 18648
Views: 4,809

Dear Helmut:

I believe the spaghetti plots you posted are actually indicative of a infusion of unbound drug.

Release of the encapsulated form follows first order kinetics and is Sequential - kind of like metabolic clearance from parent --> metabolite.

Luckily, you also posted the parent/metabolite curve for doxorubinol. Because of similarity in process, if no free drug is infused, bound and unbound PK should follow the same general shape we see in parent + metabolite.

The fact that total + free dox concentrations are colinear is pretty strong evidence for co-infusion of bound + unbound. Further, the fact that there isn't a lag time in unbound, as well as a nonlinear shape, is evidence, too.

Thanks,
BF

Complete thread:

Activity
 Admin contact
21,788 posts in 4,557 threads, 1,548 registered users;
online 5 (0 registered, 5 guests [including 3 identified bots]).
Forum time: Tuesday 18:53 CET (Europe/Vienna)

A big computer, a complex algorithm and a long time
does not equal science.    Robert Gentleman

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5